Respiratory Syncytial Virus Infection: An Illness for All Ages

Abstract

Respiratory syncytial virus (RSV) is the single most important cause of severe respiratory infection in very young infants. It has also been recently recognized as a significant cause of severe illness in elderly adults, those with underlying cardiopulmonary disease, and the immunocompromised. RSV is suspected of playing a major role in the development of asthma. Prophylaxis in high-risk infants using a monoclonal antibody is the only effective specific therapy available but recent breakthroughs in vaccine design and antiviral drugs offer the promise of effective prophylactic and therapeutic agents against RSV.

Keywords: Adults; Antivirals; Asthma; Bronchiolitis; Chronic obstructive pulmonary disease; Respiratory syncytial virus; Vaccines.